A Clinical Comparison of Two Formulations of Tobramycin 0.3% Eyedrops in the Treatment of Acute Bacterial Conjunctivitis
K. Kernt, Moises Martinez, Donata Bertin, D.W. Stroman et autres
Purpose To compare the safety and efficacy of a new enhanced viscosity ophthalmic formulation of tobramycin, given twice daily (BID), with the existing four times daily (QID) treatment regimen in patients with acute bacterial conjunctivitis. Methods This was a 12-day, multicenter, observer-masked, …
us, fi (code pays fourni par la source)